• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管性痴呆:从病理生物学到新视角。

Vascular dementia: From pathobiology to emerging perspectives.

机构信息

School of Health and Sports Sciences, Hope Park, Liverpool Hope University, Liverpool L16 9JD, United Kingdom.

School of Science, Engineering and Environment, University of Salford Manchester, Salford M5 4NT, United Kingdom.

出版信息

Ageing Res Rev. 2024 Apr;96:102278. doi: 10.1016/j.arr.2024.102278. Epub 2024 Mar 19.

DOI:10.1016/j.arr.2024.102278
PMID:38513772
Abstract

Vascular dementia (VaD) is the second most common type of dementia. VaD is synonymous with ageing, and its symptoms place a significant burden on the health and wellbeing of older people. Despite the identification of a substantial number of risk factors for VaD, the pathological mechanisms underpinning this disease remain to be fully elucidated. Consequently, a biogerontological imperative exists to highlight the modifiable lifestyle factors which can mitigate against the risk of developing VaD. This review will critically examine some of the factors which have been revealed to modulate VaD risk. The survey commences by providing an overview of the putative mechanisms which are associated with the pathobiology of VaD. Next, the factors which influence the risk of developing VaD are examined. Finally, emerging treatment avenues including epigenetics, the gut microbiome, and pro-longevity pharmaceuticals are discussed. By drawing this key evidence together, it is our hope that it can be used to inform future experimental investigations in this field.

摘要

血管性痴呆(VaD)是第二常见的痴呆类型。VaD 与衰老同义,其症状给老年人的健康和福祉带来了巨大负担。尽管已经确定了大量 VaD 的风险因素,但这种疾病的病理机制仍有待充分阐明。因此,生物老年学有必要强调可以减轻患 VaD 风险的可改变生活方式因素。本综述将批判性地检查一些已被揭示可调节 VaD 风险的因素。该调查首先概述了与 VaD 病理生物学相关的假定机制。接下来,检查了影响 VaD 发病风险的因素。最后,讨论了新兴的治疗途径,包括表观遗传学、肠道微生物组和延长寿命的药物。通过将这些关键证据汇集在一起,我们希望它可以用于为该领域的未来实验研究提供信息。

相似文献

1
Vascular dementia: From pathobiology to emerging perspectives.血管性痴呆:从病理生物学到新视角。
Ageing Res Rev. 2024 Apr;96:102278. doi: 10.1016/j.arr.2024.102278. Epub 2024 Mar 19.
2
Diagnosis and management of vascular cognitive impairment and dementia.血管性认知障碍和痴呆的诊断与管理
J Neural Transm Suppl. 2002(63):91-109. doi: 10.1007/978-3-7091-6137-1_6.
3
Nutrition and vascular dementia.营养与血管性痴呆。
J Nutr Health Aging. 2012 Apr;16(4):319-24. doi: 10.1007/s12603-012-0042-z.
4
Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia.中年与晚年抑郁症状及痴呆风险:对阿尔茨海默病和血管性痴呆的不同影响
Arch Gen Psychiatry. 2012 May;69(5):493-8. doi: 10.1001/archgenpsychiatry.2011.1481.
5
Models and mechanisms of vascular dementia.血管性痴呆的模型与机制
Exp Neurol. 2015 Oct;272:97-108. doi: 10.1016/j.expneurol.2015.05.006. Epub 2015 May 15.
6
Vascular dementia may be the most common form of dementia in the elderly.血管性痴呆可能是老年人中最常见的痴呆形式。
J Neurol Sci. 2002 Nov 15;203-204:7-10. doi: 10.1016/s0022-510x(02)00252-6.
7
Neuroprotection in vascular dementia.血管性痴呆中的神经保护作用
Cerebrovasc Dis. 2006;21 Suppl 2:106-17. doi: 10.1159/000091710. Epub 2006 May 2.
8
Effect of alcohol and tobacco use on vascular dementia: a matched case control study.酒精和烟草使用对血管性痴呆的影响:一项配对病例对照研究。
Vasc Health Risk Manag. 2011;7:685-91. doi: 10.2147/VHRM.S26194. Epub 2011 Nov 15.
9
Facts, myths, and controversies in vascular dementia.血管性痴呆中的事实、误解与争议
J Neurol Sci. 2004 Nov 15;226(1-2):49-52. doi: 10.1016/j.jns.2004.09.011.
10
Classification, diagnosis and treatment of vascular dementia.血管性痴呆的分类、诊断与治疗
Drugs Aging. 1997 Nov;11(5):361-73. doi: 10.2165/00002512-199711050-00004.

引用本文的文献

1
Herb-Drug Interaction Between Sailuotong and Pitavastatin: A Systematic Pharmacokinetic Investigation and Mechanism Analysis.脉络通与匹伐他汀的草药-药物相互作用:一项系统的药代动力学研究及机制分析。
Drug Des Devel Ther. 2025 Aug 20;19:7135-7149. doi: 10.2147/DDDT.S529385. eCollection 2025.
2
Total flavonoids of L. alleviate cognitive impairment via TNF-α/NF-κB p65 signaling pathway in vascular dementia rats.刺蒺藜总黄酮通过TNF-α/NF-κB p65信号通路减轻血管性痴呆大鼠的认知障碍。
Front Pharmacol. 2025 Aug 6;16:1640272. doi: 10.3389/fphar.2025.1640272. eCollection 2025.
3
Elucidating molecular pathogenesis and developing targeted therapeutic interventions for cerebrovascular endothelial cell-mediated vascular dementia.
阐明脑血管内皮细胞介导的血管性痴呆的分子发病机制并开发靶向治疗干预措施。
Front Aging Neurosci. 2025 Jul 16;17:1623050. doi: 10.3389/fnagi.2025.1623050. eCollection 2025.
4
Mechanism of heme oxygenase-1 regulation of ferroptosis in vascular dementia.血红素加氧酶-1对血管性痴呆中铁死亡的调控机制。
Front Mol Neurosci. 2025 Jun 26;18:1585079. doi: 10.3389/fnmol.2025.1585079. eCollection 2025.
5
NSC-derived extracellular vesicles-mediates neuronal plasticity enhancement in vascular dementia via transferring miR-210.源自神经干细胞的细胞外囊泡通过转运miR-210介导血管性痴呆中神经元可塑性的增强。
Acta Neuropathol Commun. 2025 Jul 9;13(1):152. doi: 10.1186/s40478-025-02073-1.
6
Association between stroke and memory diseases: evidence from a prospective national cohort study in China.中风与记忆疾病之间的关联:来自中国一项前瞻性全国队列研究的证据。
Front Neurol. 2025 Jun 19;16:1578200. doi: 10.3389/fneur.2025.1578200. eCollection 2025.
7
Investigating Aging and DNA Methylation: A Path to Improving Health Span?探索衰老与DNA甲基化:延长健康寿命之路?
Yale J Biol Med. 2025 Jun 30;98(2):237-244. doi: 10.59249/BYOI5042. eCollection 2025 Jun.
8
Blood-Brain Barrier (BBB) Dysfunction in CNS Diseases: Paying Attention to Pericytes.中枢神经系统疾病中的血脑屏障功能障碍:关注周细胞
CNS Neurosci Ther. 2025 May;31(5):e70422. doi: 10.1111/cns.70422.
9
Lipocalin 2 Facilitates the Initial Compromise of the Blood-Brain Barrier Integrity in Chronic Cerebral Hypoperfusion.脂质运载蛋白2促进慢性脑灌注不足时血脑屏障完整性的初始破坏。
CNS Neurosci Ther. 2025 May;31(5):e70438. doi: 10.1111/cns.70438.
10
Cardiovascular Dysautonomia in Patients with Parkinson's Disease and Hypertension: A Cross-Sectional Pilot Study.帕金森病合并高血压患者的心血管自主神经功能障碍:一项横断面试点研究。
J Clin Med. 2025 Mar 25;14(7):2225. doi: 10.3390/jcm14072225.